Ident. | Authors (with country if any) | Title |
---|
000022 |
Pv Dissanayake [Royaume-Uni] ; R. Wasala [Royaume-Uni] | Wolff-parkinson-white syndrome diagnosed following binge drinking associated arrhythmia |
000029 |
Claire L. Tomlinson [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Charmaine Meek [Royaume-Uni] ; Clare P. Herd [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Rebecca Stowe [Royaume-Uni] ; Laila Shah [Royaume-Uni] ; Catherine Sackley [Royaume-Uni] ; Katherine H O. Deane [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Natalie Ives [Royaume-Uni] | Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis |
000048 |
Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko Krüger | A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants |
000067 |
Zhijun Yao [République populaire de Chine] ; Bin Hu [République populaire de Chine, Royaume-Uni] ; Lina Zhao [République populaire de Chine] ; Chuanjiang Liang [République populaire de Chine] | Analysis of Gray Matter in AD Patients and MCI Subjects Based Voxel-Based Morphometry |
000120 |
Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Alfonso Fasano [Italie] ; Andrea E. Cavanna [Royaume-Uni] | The prevalence and clinical characteristics of punding in Parkinson's disease |
000155 |
Carl E. Clarke [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops? |
000260 |
Rebecca Stowe [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Kelly Handley [Royaume-Uni] ; Alexandra Furmston [Royaume-Uni] ; Katherine Deane [Royaume-Uni] ; J. J. Van Hilten [Pays-Bas] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease |
000532 |
Claire L. Tomlinson [Royaume-Uni] ; Rebecca Stowe [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Richard Gray [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] | Systematic review of levodopa dose equivalency reporting in Parkinson's disease |
000D14 |
Hani T. S. Benamer [Royaume-Uni] ; Rajith De Silva [Royaume-Uni] ; Khurram A. Siddiqui ; Donald G. Grosset [Royaume-Uni] | Parkinson's disease in Arabs: A systematic review |
000E64 |
Carl E. Clarke [Royaume-Uni] | Are delayed‐start design trials to show neuroprotection in Parkinson's disease fundamentally flawed? |
000F60 |
Nir Giladi [Israël] ; Babak Boroojerdi [Allemagne] ; Amos D. Korczyn [Israël] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Rotigotine transdermal patch in early Parkinson's disease: A randomized, double‐blind, controlled study versus placebo and ropinirole |
001136 |
D. Grosset [Royaume-Uni] ; L. Taurah [Royaume-Uni] ; D J Burn [Royaume-Uni] ; D. Macmahon [Royaume-Uni] ; A. Forbes [Royaume-Uni] ; K. Turner [Royaume-Uni] ; A. Bowron [Royaume-Uni] ; R. Walker [Royaume-Uni] ; L. Findley [Royaume-Uni] ; O. Foster [Royaume-Uni] ; K. Patel [Royaume-Uni] ; C. Clough [Royaume-Uni] ; B. Castleton [Royaume-Uni] ; S. Smith [Royaume-Uni] ; G. Carey [Royaume-Uni] ; T. Murphy [Royaume-Uni] ; J. Hill [Royaume-Uni] ; U. Brechany [Royaume-Uni] ; P. Mcgee [Royaume-Uni] ; S. Reading [Royaume-Uni] ; G. Brand [Royaume-Uni] ; L. Kelly [Royaume-Uni] ; K. Breen [Royaume-Uni] ; S. Ford [Royaume-Uni] ; M. Baker [Royaume-Uni] ; A. Williams [Royaume-Uni] ; J. Hearne [Royaume-Uni] ; N. Qizilbash [Royaume-Uni] ; K Ray Chaudhuri [Royaume-Uni] | A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis |
001185 |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease |
001322 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
001411 |
N A Hamid [Royaume-Uni] ; R D Mitchell [Royaume-Uni] ; P. Mocroft [Royaume-Uni] ; G W M. Westby [Royaume-Uni] ; J. Milner [Royaume-Uni] ; H. Pall [Royaume-Uni] | Targeting the subthalamic nucleus for deep brain stimulation: technical approach and fusion of pre- and postoperative MR images to define accuracy of lead placement |
001448 |
A. C. Williams ; L. S. Cartwright [Royaume-Uni] ; D. B. Ramsden [Royaume-Uni] | Parkinson's disease: the first common neurological disease due to auto-intoxication? |
001461 |
Naheed L. Khan ; Shushant Jain ; John M. Lynch ; Nicola Pavese ; Patrick Abou-Sleiman ; Janice L. Holton ; Daniel G. Healy ; William P. Gilks ; Mary G. Sweeney ; Milan Ganguly ; Vaneesha Gibbons ; Sonia Gandhi ; Jenny Vaughan ; Louise H. Eunson ; Regina Katzenschlager ; Juliet Gayton ; Graham Lennox ; Tamas Revesz ; David Nicholl [Royaume-Uni] ; Kailash P. Bhatia ; Niall Quinn ; David Brooks ; Andrew Lees (neurologue) [Royaume-Uni] ; Mary B. Davis ; Paola Piccini ; Andrew B. Singleton [États-Unis] ; Nicholas W. Wood | Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data |
001499 |
M. Péchevis [France] ; C. E. Clarke [Royaume-Uni] ; P. Vieregge [Allemagne] ; B. Khoshnood [France] ; C. Deschaseaux-Voinet [France] ; G. Berdeaux [France] ; M. Ziegler [France] | Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study |
001673 |
Carl E. Clarke [Royaume-Uni] | A “cure” for Parkinson's disease: Can neuroprotection be proven with current trial designs? |
001831 |
Katherine H. O. Deane [Royaume-Uni] ; Caroline Ellis-Hill [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; E. Diane Playford [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] | Systematic review of paramedical therapies for Parkinson's disease |
001998 |
Ernest W. Lau [Royaume-Uni] ; G. André Ng [Royaume-Uni] ; Michael J. Griffith [Royaume-Uni] | Variability in the Manifestation of Pre‐excited Atrial Fibrillation: Its Quantification, Theoretical Origin, and Diagnostic Potential |
001D03 |
Karen M. Rudolph [États-Unis] ; Marilyn J. Crain [Royaume-Uni] ; Alan J. Parkinson [États-Unis] ; Marilyn C. Roberts | Characterization of a Multidrug-Resistant Clone of Invasive Streptococcus pneumoniae Serotype 6B in Alaska Using Pulsed-Field Gel Electrophoresis and PspA Serotyping |
002033 |
V. V. Myllyl [Finlande] ; M. Jackson [Royaume-Uni] ; J. P. Larsen [Norvège] ; H. Baas [Allemagne] | Efficacy and safety of tolcapone in levodopa‐treated Parkinson's disease patients with “wearing‐off” phenomenon: a multicentre, double‐blind, randomized, placebo‐controlled trial |
002D37 |
J. W. Warburton [Royaume-Uni] | Memory disturbance and the Parkinson syndrome |